The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Activation of the p62–Keap1–NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Open accessAbstract
Ferroptosis is a recently recognized form of regulated cell death caused by an iron‐dependent accumulation of lipid reactive oxygen species. However, the molecular mechanisms regulating ferroptosis remain obscure. Here, we report that nuclear factor erythroid 2‐related factor 2 (NRF2) plays a central role in protecting hepatocellular carcinoma (HCC) cells against ferroptosis. Upon exposure to ferroptosis‐inducing compounds (e.g., erastin, sorafenib, and buthionine sulfoximine), p62 expression prevented NRF2 degradation and enhanced subsequent NRF2 nuclear accumulation through inactivation of Kelch‐like ECH‐associated protein 1. Additionally, nuclear NRF2 interacted with transcriptional coactivator small v‐maf avian musculoaponeurotic fibrosarcoma oncogene homolog proteins such as MafG and then activated transcription of quinone oxidoreductase‐1, heme oxygenase‐1, and ferritin heavy chain‐1. Knockdown of p62, quinone oxidoreductase‐1, heme oxygenase‐1, and ferritin heavy chain‐1 by RNA interference in HCC cells promoted ferroptosis in response to erastin and sorafenib. Furthermore, genetic or pharmacologic inhibition of NRF2 expression/activity in HCC cells increased the anticancer activity of erastin and sorafenib in vitro and in tumor xenograft models. Conclusion: These findings demonstrate novel molecular mechanisms and signaling pathways of ferroptosis; the status of NRF2 is a key factor that determines the therapeutic response to ferroptosis‐targeted therapies in HCC cells. (H epatology 2016;63:173–184)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Phosphorylation of p62 initiates its interaction with E3 ligase KEAP1, therefore competing out alternate KEAP1 target Nrf2 and stabilizing Nrf2 signaling [102].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [102]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,974
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,001
Tang, C., He, C., Wang, D., Guo, J. F., Yin, X., Ye, H., Wu, L., Zhang, Y., Zeng, S., Zeng, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65056-9 · Cited by 36
Potential mechanism of ferroptosis in pancreatic cancer (Review)
Chen, G., Guo, G., Zhou, X., & Chen, H. (2019) · Oncology Letters · doi:10.3892/ol.2019.11159 · Cited by 37
Yasuda, D., Ohe, T., Takahashi, K., Imamura, R. M., Kojima, H., Okabe, T., Ichimura, Y., Komatsu, M., Yamamoto, M. P., Nagano, T., et al. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1732955 · Cited by 36
Heme Oxygenase-1 in Central Nervous System Malignancies
Sferrazzo, G., Rosa, M. D., Barone, E., Volti, G. L., Musso, N., Tibullo, D., & Barbagallo, I. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051562 · Cited by 36
DUSP1 Blocks autophagy-dependent ferroptosis in pancreatic cancer
Xie, Y., Kuang, F., Liu, J., Tang, D., & Kang, R. (2020) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000054 · Cited by 36
Self-citationThe Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance
Chen, Z., Yan, Y., Qi, C., Liu, J., Li, L., & Wang, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.733229 · Cited by 36
Wang, F., Graham, E. T., Naowarojna, N., Shi, Z., Wang, Y., Xie, G., Zhou, L., Salmon, W. C., Jia, J., Wang, X., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.11.001 · Cited by 35
Ferroptosis in hematological malignancies and its potential network with abnormal tumor metabolism
Zhang, J., Liu, Y., Li, Q., Xu, A., Hu, Y., & Sun, C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112747 · Cited by 36
Liu, H., Zhao, L., Wang, M., Yang, K., Jin, Z., Zhao, C., & Shi, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852095 · Cited by 36
Shueng, P., Chan, H., Lin, W.-C., Kuo, D., & Chuang, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126501 · Cited by 36
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
Zhang, C., Wang, C., Yang, Z., Bai, Y., Shukuya, T., Poh, M. E., Ekman, S., Li, J., Xu, Y., & Deng, S. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-318 · Cited by 40
Targeting the Macrophage-Ferroptosis Crosstalk: A Novel Insight into Tumor Immunotherapy
Zhou, Z., Xu, B., Hu, N., Guo, Z., Bao, W., Shao, B., & Yang, W. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2707203 · Cited by 37
The crosstalk effect between ferrous and other ions metabolism in ferroptosis for therapy of cancer
Ke, K., Li, L., Lü, C., Zhu, Q., Wang, Y., Mou, Y., Wang, H., & Jin, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.916082 · Cited by 36
Chen, J., Niu, C., Yang, N., Liu, C., Zou, S., & Zhu, S. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106674 · Cited by 35
Research progress and insights on the role of ferroptosis in wound healing
Bi, M., Li, D., & Zhang, J. (2023) · International Wound Journal · doi:10.1111/iwj.14102 · Cited by 34
The role of ferroptosis in metabolic diseases
Xie, L., Fang, B., & Zhang, C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119480 · Cited by 35
Elkateb, A. S., Nofal, S., Ali, S. A. E.-M., & Atya, H. B. (2023) · Inflammation · doi:10.1007/s10753-023-01823-4 · Cited by 35
Hou, H., Qin, X., Li, G., Cui, Z., Zhang, J., Dong, B., Wang, Z., & Zhao, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-53976-3 · Cited by 35
Zhang, H., Li, S., Liu, S. M., Liao, Y., Liu, H., Yang, M., & Chen, P. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02491-8 · Cited by 44
Tian, B., Lu, Z.-N., & Guo, X. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.12.014 · Cited by 35
Kim, S., Saeidi, S., Cho, N., Kim, S. H., Lee, H., Han, W., Noh, D., & Surh, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.047 · Cited by 35
Activation of Nrf2 signaling protects hypoxia‐induced HTR ‐8/ SVneo cells against ferroptosis
Wang, Y., Zhang, L., & Zhou, X. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15009 · Cited by 35
Hemin enhances radiosensitivity of lung cancer cells through ferroptosis
Almahi, W. A., Yu, K. N., Mohammed, F., Kong, P., & Han, W. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112946 · Cited by 35
GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma
Zhou, Y., Wu, H., Wang, F., Xu, L., Yan, Y., Tong, X., & Yan, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.802124 · Cited by 35
Global Characteristics and Trends in Research on Ferroptosis: A Data‐Driven Bibliometric Study
Dong, X., Tan, Y., Zhuang, D., Hu, T., & Zhao, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8661864 · Cited by 35
Tan, P., Li, M., Liu, Z., Li, T., Zhao, L., & Fu, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.937413 · Cited by 36
LncRNA A2M-AS1 Promotes Ferroptosis in Pancreatic Cancer via Interacting With PCBP3
Qiu, X., Shi, Q., Zhang, X., Shi, X., Jiang, H., & Qin, S. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0024 · Cited by 35
Song, C., Li, D., Zhang, J., & Zhao, X. (2023) · Food & Function · doi:10.1039/d2fo03331c · Cited by 35
The role and regulation of Maf proteins in cancer
Deng, Y., Lu, L., Zhang, H., Fu, Y., Liu, T., & Chen, Y. (2023) · Biomarker Research · doi:10.1186/s40364-023-00457-w · Cited by 36
Ye, Y., Xu, L., Zhang, L., Zhao, P., Cai, W., Fu, G., Wang, T., Tao, Z., Shi, W., Gu, W. J., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103137 · Cited by 34
Ficolin 3 promotes ferroptosis in HCC by downregulating IR/SREBP axis-mediated MUFA synthesis
Yuan, Y., Xu, J., Jiang, Q., Yang, C., Wang, N., Liu, X., Piao, H.-L., Lu, S., Zhang, X., Liu, H., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03047-2 · Cited by 34
From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders
He, Y., Lin, Y., Song, J., Song, M., Nie, X., Sun, H. J., Xu, C., Han, Z., & Cai, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02121-2 · Cited by 36
Lange, M., Abhari, B. A., Hinrichs, T. M., Fulda, S., & Liese, J. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.011 · Cited by 34
Ferroptosis As Ultimate Target of Cancer Therapy
Motooka, Y., & Toyokuni, S. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0048 · Cited by 36
FGF4 improves hepatocytes ferroptosis in autoimmune hepatitis mice via activation of CISD3
Jiang, H., Fang, Y., Wang, Y., Li, T., Lin, H., Lin, J., Pan, T., Liu, Q., Lv, J., Chen, D., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109762 · Cited by 34
Self-citationHiromatsu, M., Toshida, K., Itoh, S., Harada, N., Kohashi, K., Oda, Y., & Yoshizumi, T. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-14053-7 · Cited by 33
A guide to ferroptosis, the biological rust of cellular membranes
Veeckmans, G., San, E. V., & Berghe, T. V. (2023) · FEBS Journal · doi:10.1111/febs.16993 · Cited by 35
Erastin induces ferroptosis in cervical cancer cells via Nrf2/HO-1 signaling pathway
Wei, X., Huang, Q., Huang, J., Yu, L., & Chen, J. (2023) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320231219348 · Cited by 33
BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1
Cao, Y., Wang, X., Liu, Y., Liu, P., Qin, J., Zhu, Y., Zhai, S., Jiang, Y., Liu, Y., Han, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202306298 · Cited by 36
KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
Li, J., Shi, D., Li, S., Shi, X., Liu, Y., Zhang, Y., Wang, G., Zhang, C., Xia, T., Piao, H., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06563-3 · Cited by 36
CRISPR-Cas9 gene editing strengthens cuproptosis/chemodynamic/ferroptosis synergistic cancer therapy
Wu, X., Bai, Z., Wang, H., Wang, H., Hou, D., Xu, Y., Wo, G., Cheng, H., Sun, D., & Tao, W. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.029 · Cited by 35
The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer
Baiskhanova, D. M., & Schäfer, H. (2024) · Antioxidants · doi:10.3390/antiox13060696 · Cited by 35
Khan, G., Hussain, M. S., Khan, Y., Fatima, R., Ahmad, S., Sultana, A., & Alam, P. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149776 · Cited by 35
Nrf2: A unifying transcription factor in the pathogenesis of Fuchs’ endothelial corneal dystrophy
Lovatt, M., Kocaba, V., Neo, D. J. H., Soh, Y. Q., & Mehta, J. S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101763 · Cited by 33
Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment
Huang, R., Dong, R., Wang, N., He, Y., Zhu, P., Wang, C., Lan, B., Gao, Y., & Sun, L. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01092-5 · Cited by 36
A case–control study in Taiwanese cohort and meta-analysis of serum ferritin in pancreatic cancer
Park, J. M., Mau, C.-Z., Chen, Y., Su, Y., Chen, H. A., Huang, S., Chang, J., & Chiu, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-00650-7 · Cited by 33
Lu, Z., Liu, Z., & Fang, B. (2022) · Bioengineered · doi:10.1080/21655979.2022.2036895 · Cited by 32
Apatinib Induces Ferroptosis of Glioma Cells through Modulation of the VEGFR2/Nrf2 Pathway
Xia, L., Gong, M., Zou, Y., Wang, Z., Wu, B., Zhang, S., Li, L., Jin, K., & Sun, C. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9925919 · Cited by 33
Ye, J., Peng, J., Liu, K., Zhang, T., & Huang, W. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00354.2021 · Cited by 35
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma
Huang, Z., Xia, H., Cui, Y., Yam, J. W. P., & Xu, Y. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00255 · Cited by 34
Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis
Alannan, M., Fatrouni, H., Trézéguet, V., Dittrich-Domergue, F., Moreau, P., Siegfried, G., Liet, B., Khatib, A., Grosset, C. F., Badran, B. M., et al. (2022) · Cells · doi:10.3390/cells12010062 · Cited by 35
Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy
Yin, W., Chang, J., Sun, J., Zhang, T., Zhao, Y., Li, Y., & Dong, H. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb02161g · Cited by 32
The potential of ferroptosis combined with radiotherapy in cancer treatment
Lu, Z., Xiao, B., Chen, W., Tang, T., Zhuo, Q., & Chen, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1085581 · Cited by 35
Rahbardar, M. G., & Hosseinzadeh, H. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02487-5 · Cited by 32
The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario
Mukherjee, A. G., & Gopalakrishnan, A. V. (2023) · Medical Oncology · doi:10.1007/s12032-023-02124-4 · Cited by 33
Zhang, C.-H., Yan, Y.-J., & Luo, Q. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122439 · Cited by 38
Ferroptosis and its role in osteoarthritis: mechanisms, biomarkers, and therapeutic perspectives
Lu, S., Liu, Z., Qi, M., Wang, Y., Chang, L., Bai, X., Jiao, Y., Chen, X., & Zhen, J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1510390 · Cited by 33
Moxibustion Exerts a Neuroprotective Effect through Antiferroptosis in Parkinson’s Disease
Lu, J., Liu, X., Tian, Y., Li, H., Ren, Z., Liang, S., Zhang, G., Zhao, C., Li, X., Wang, T., et al. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2735492 · Cited by 32
Self-citationRole of the KEAP1-NRF2 Axis in Renal Cell Carcinoma
Clerici, S., & Boletta, A. (2020) · Cancers · doi:10.3390/cancers12113458 · Cited by 36
Yan, Y., Cai, J., Huang, Z., Cao, X., Tang, P., Wang, Z., Zhang, F., Xia, S., & Shen, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.712230 · Cited by 33
Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis
Lachowicz, J. I., Pichiri, G., Piludu, M., Fais, S., Orrù, G., Congiu, T., Piras, M., Faa, G., Fanni, D., Torre, G. D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010551 · Cited by 32
Cheng, K., Guo, Q., Shen, Z., Yang, W., Zhou, Y., Sun, Z., Yao, X., & Wu, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.948389 · Cited by 33
Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases
You, H., Wang, L., Bu, F., Meng, H., Huang, C., Fang, G.-Y., & Li, J. (2022) · Cells · doi:10.3390/cells11203301 · Cited by 33
Miao, Y., Quan, W., Dong, X., Gan, J., Ji, C.-F., Wang, J., & Zhang, F. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01421-1 · Cited by 33
Kam, C. S., Ho, D. W., Ming, V. S., Tian, L., Sze, K. M., Zhang, V. X., Tsui, Y., Husain, A., Lee, J. M., Wong, C. C., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.004 · Cited by 31
TXNDC12 inhibits lipid peroxidation and ferroptosis
Tang, L., Yu, Y., Deng, W., Liu, J., Wang, Y., Ye, F., Kang, R., Tang, D., & He, Q. (2023) · iScience · doi:10.1016/j.isci.2023.108393 · Cited by 30
Self-citationA Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives
Han, Z., Luo, Y., Chen, H., Zhang, G., You, L., Zhang, M., Lin, Y., Lan, Y., & Zhou, S. (2024) · Kidney Diseases · doi:10.1159/000538106 · Cited by 32
Yan, L., Hu, H., Feng, L., Li, Z., Chunyan, Z., Zhang, J., Yin, X., & Li, B. (2024) · Medical Oncology · doi:10.1007/s12032-024-02483-6 · Cited by 33
Zhang, C., Yang, T., Chen, H., Ding, X., Chen, H., Liang, Z., Zhao, Y., Ma, S., & Liu, X. (2025) · Cell Death and Disease · doi:10.1038/s41419-024-07317-x · Cited by 35
Mitochondrial CCN1 drives ferroptosis via fatty acid β-oxidation
Guo, W., Zhang, C.-C., Zhou, Q., Chen, T., Xu, X., Zhang, J., Yu, X., Wu, H., Zhang, X., Ma, L., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.04.004 · Cited by 33
Self-citationSun, Z., Li, T., Xiao, C., Zou, S., Zhang, M., Zhang, Q., Wang, Z., Zhan, H., & Wang, H. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-022-02555-9 · Cited by 32
Ferroptosis: A new strategy for traditional Chinese medicine treatment of stroke
Lou, Y., Ma, M., Jiang, Y., Xu, H., Gao, Z., Gao, L., & Wang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113806 · Cited by 32
Xiu, Z., Li, Y., Fang, J., Han, J., Li, S., Li, Y., Yang, X., Song, G., Li, Y., Jin, N., et al. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s395617 · Cited by 32
Wei, J., Wang, L., Zhang, Y., Sun, T., Zhang, C., Hu, Z., Zhou, L., Liu, X., Wan, J., & Ma, L. (2023) · Oncogene · doi:10.1038/s41388-023-02717-3 · Cited by 31
Iron metabolism and ferroptosis in diabetic bone loss: from mechanism to therapy
Bao, J., Yan, Y., Zuo, D., Zhuo, Z., Sun, T., Lin, H., Han, Z., Zhao, Z., & Yu, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1178573 · Cited by 33
RETRACTED ARTICLE: Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer
Xu, C., Wang, X., Zhou, Y., Chen, F., Wang, H., Li, K., Fan, H., Tang, X., Jiang, G., & Zhang, J. (2019) · Oncogene · doi:10.1038/s41388-019-0930-3 · Cited by 30
RetractedLiu, C., Liu, X., Ouyang, P.-W., Liu, Q., Huang, X., Xiao, F., Cui, Y., Zhou, Q., & Pan, H. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109347 · Cited by 30
Ferroptosis: Mechanism and potential applications in cervical cancer
Chang, X., & Miao, J. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1164398 · Cited by 30
You, J., Ouyang, S., Xie, Z., Zhi, C., Jiang, Y. L., Tan, X., Li, P., Lin, X., Ma, W., Liu, Z., et al. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31045 · Cited by 30
Tong, R., Feng, X., Sun, J., Ling, Z., Wang, J., Li, S., Yang, B., Deng, J., He, G., & Wu, J. (2023) · Small · doi:10.1002/smll.202307273 · Cited by 30
Ferroptosis: a novel mechanism of cell death in ophthalmic conditions
Yang, Y., Lin, Y., Han, Z., Wang, B., Zheng, W., & Wei, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1440309 · Cited by 32
Ferroptosis in hepatocellular carcinoma: Mechanisms and therapeutic implications
Tu, S., Zou, Y., Yang, M., Zhou, X., Xu, Z., Jiang, Y., Wang, H., Chen, B., Qian, Q., Dou, X., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117769 · Cited by 30
Liu, M., Liu, S., Lin, Z.-H., Chen, X., Jiao, Q., Du, X., & Jiang, H. F. (2025) · Biomolecules · doi:10.3390/biom15010149 · Cited by 32
Small Molecular Nrf2 Inhibitors as Chemosensitizers for Cancer Therapy
Lin, H., Qiao, Y., Yang, H., Nan, Q., Qu, W., Feng, F., Liu, W., Chen, Y., & Sun, H. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0285 · Cited by 30
Fasting Drives Nrf2-Related Antioxidant Response in Skeletal Muscle
Lettieri‐Barbato, D., Minopoli, G., Caggiano, R., Izzo, R., Santillo, M., Aquilano, K., & Faraonio, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207780 · Cited by 29
Peng, Y., Yu, H., Zhang, Y., Qu, F., Tang, Z., Qu, C., Tian, J., Zong, B., Wang, Y., Ren, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97102-z · Cited by 30
Song, C., Li, D., Zhang, J., & Zhao, X. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115852 · Cited by 30
MTHFR inhibits TRC8‐mediated HMOX1 ubiquitination and regulates ferroptosis in ovarian cancer
Wang, X., Xu, Z., Ren, X., Chen, X., Yi, Q., Zeng, S., Thakur, A., Gong, Z., & Yan, Y. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1013 · Cited by 30
Mori fructus aqueous extracts attenuates liver injury by inhibiting ferroptosis via the Nrf2 pathway
Wei, Y., Gao, C., Wang, H.-R., Zhang, Y.-N., Gu, J.-H., Zhang, X.-Y., Gong, X.-H., & Hao, Z.-H. (2023) · Journal of Animal Science and Biotechnology · doi:10.1186/s40104-023-00845-0 · Cited by 27
Sun, L., He, X., Kong, J., Yu, H., & Wang, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111316 · Cited by 30
Male Infertility: Shining a Light on Lipids and Lipid-Modulating Enzymes in the Male Germline
Walters, J. L. H., Gadella, B. M., Sutherland, J. M., Nixon, B., & Bromfield, E. G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020327 · Cited by 30
Molecular mechanisms of ferroptosis and its antitumor applications in natural products
Yu, D., Wang, Q., Zhang, Q., Cai, M., Liu, S., & Zhang, W. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023120 · Cited by 30
Role of ferroptosis in radiation-induced soft tissue injury
Berry, C. E., Kendig, C. B., An, N., Fazilat, A. Z., Churukian, A. A., Griffin, M., Pan, P. M., Longaker, M. T., Dixon, S. J., & Wan, D. C. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02003-5 · Cited by 33
Broadening horizons: the role of ferroptosis in polycystic ovary syndrome
Wang, M., Zhang, B.-Q., Ma, S., Xu, Y. J., Zhao, D.-H., Zhang, J., Li, C.-J., Zhou, X., & Zheng, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1390013 · Cited by 29
Ferroptosis and oral squamous cell carcinoma: connecting the dots to move forward
Antonelli, A., Battaglia, A. M., Sacco, A., Petriaggi, L., Giorgio, E., Barone, S., Biamonte, F., & Giudice, A. (2024) · Frontiers in Oral Health · doi:10.3389/froh.2024.1461022 · Cited by 32
Nanobiotechnology boosts ferroptosis: opportunities and challenges
Han, S., Zou, J., Xiao, F., Xian, J., Liu, Z., Li, M., Luo, W., Feng, C., & Kong, N. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02842-5 · Cited by 34
Ferroptosis and Its Potential Role in the Physiopathology of Skeletal Muscle Atrophy
Sun, C., Xiao, J.-L., Sun, C., & Tang, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212463 · Cited by 30
Meng, F., Li, H., Huang, Y., Wang, C., Liu, Y., Zhang, C., Chen, D., Zeng, T., Zhang, S., Li, Y., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-00984-5 · Cited by 31
Self-citationRecent progress in nanotechnology based ferroptotic therapies for clinical applications
Xu, Y., Qin, Z., Ma, J., Cao, W., & Zhang, P. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173198 · Cited by 30
Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
Liao, H., Shi, J., Wen, K., Lin, J., Liu, Q., Shi, B., Yan, Y., & Xiao, Z. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s325593 · Cited by 28
Metadata
- Authors
- Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D.
- Affiliations
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- University of Pittsburgh (US)
- Corresponding author
- Tang, Daolin
- Venue
- Hepatology
- Published
- 2015-11-26
- Volume
- 63
- Issue
- 1
- Pages
- 173-184
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- PMC
- PMC4688087
- OpenAlex
- W2163005196
- Cited by
- 2,012
- References
- 40
- Citations by year
- 2026: 165 · 2025: 255 · 2024: 311 · 2023: 309 · 2022: 342 · 2021: 255 · 2020: 165 · 2019: 92 · 2018: 52 · 2017: 30 · 2016: 26 · 2015: 2
- FWCI
- 29.04
- Type
- journal article
- Language
- en
- Update notices
- correction (2025-08-01)
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Pittsburgh
- National Natural Science Foundation of China (201508020258, R01GM115366, 201400000003, R01CA160417, 81502445, 31171229, U1132005)
- National Institutes of Health (R01GM115366 to D.T.)
- National Cancer Institute (R01CA160417)
- National Institute of General Medical Sciences (R01GM115366)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- ferroptosis, Nrf2, p62, Keap1, hepatocellular carcinoma, erastin, sorafenib, buthionine sulfoximine, quinone oxidoreductase 1, heme oxygenase-1, FTH1, MAFG, ferroptosis-targeted therapy, iron-dependent lipid peroxidation
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Animals, Carcinoma, Hepatocellular, Humans, Iron, Liver Neoplasms, Mice, Inbred C57BL, Tumor Cells, Cultured, Signal Transduction, RNA-Binding Proteins, Cell Death, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review